Philips Respironics Issues Recall for Trilogy EVO and EV300 Ventilators Over Nebulizer Compatibility
Areazine synthesizes this Health Canada recall directly from Health Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
Philips Respironics has prohibited the use of non-pneumatic nebulizers with Trilogy EVO and EV300 ventilators due to risks of aerosol deposition on internal flow sensors.
What this Health Canada recall tells you, and what most readers miss
This notice was issued by Health Canada on April 6, 2026 and geographically references Canada. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Product & Food Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, health-canada, MedicalDevices.
What Happened
Philips Respironics (operating as Respironics Inc.) has issued a health product recall regarding the Trilogy EVO platform ventilators. The company is no longer permitting the use of non-pneumatic nebulizers, such as vibrating mesh nebulizers, with these devices. This decision follows reports of nebulized aerosol deposition on the internal flow sensor, which can compromise the safe operation of the equipment. This update serves as a follow-up to previous field safety notices (FSN 2025-CC-SRC-020 and FSN 2024-CC-SRC-013) regarding flow sensor issues.
Which Products Are Affected
The recall affects the following Trilogy EVO platform ventilators:
- Trilogy EVO: Model/Catalogue Number CA2110X12B
- Trilogy EV300: Model/Catalogue Number CA2200X12B
- Trilogy EVO O2: Included as part of the Trilogy EVO platform collective.
The affected products were manufactured by Respironics Inc., also trading as Philips RS North America LLC, located in Murrysville, Pennsylvania.
What You Should Do
Healthcare providers and consumers must immediately cease the use of non-pneumatic (vibrating mesh) nebulizers with the affected Trilogy EVO, Trilogy EVO O2, and Trilogy EV300 ventilators. Users should refer to the updated field safety notices provided by Philips Respironics to ensure the continued safe and compliant operation of the ventilators.
Why This Matters
This restriction is critical because aerosol deposition on the internal flow sensor can lead to device malfunction. Ensuring the integrity of the flow sensor is essential for the ventilator to provide accurate respiratory support to patients.
Source
For more information, visit the official Health Canada recall notice.
Original source: Health Canada Official Notice ↗
Related Product & Food Recalls
All Product & Food Recalls →Frequently Asked Questions
Common questions about this Health Canada recall.